Cargando…
Dietary Aspects and Drug-Related Side Effects in Autosomal Dominant Polycystic Kidney Disease Progression
Autosomal dominant polycystic kidney disease (ADPKD) is the most commonly inherited kidney disease. In the absence of targeted therapies, it invariably progresses to advanced chronic kidney disease. To date, the only approved treatment is tolvaptan, a vasopressin V2 receptor antagonist that has been...
Autores principales: | Quiroga, Borja, Torra, Roser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658114/ https://www.ncbi.nlm.nih.gov/pubmed/36364911 http://dx.doi.org/10.3390/nu14214651 |
Ejemplares similares
-
Recent advances in the clinical management of autosomal dominant polycystic kidney disease
por: Torra, Roser
Publicado: (2019) -
Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013) -
Autosomal dominant polycystic kidney disease: possibly the least silent cause of chronic kidney disease
por: Torra, Roser, et al.
Publicado: (2021) -
Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease
por: Naranjo, Javier, et al.
Publicado: (2021) -
Autosomal dominant polycystic kidney disease in young adults
por: Martínez, Víctor, et al.
Publicado: (2022)